skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

Patent ·
OSTI ID:1171656

(1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-98CH10886
Assignee:
Catalyst Pharmaceutical Partners (Coral Gables, FL)
Patent Number(s):
8,969,413
Application Number:
13/581,187
OSTI ID:
1171656
Resource Relation:
Patent File Date: 2011 Feb 25
Country of Publication:
United States
Language:
English

References (4)


Similar Records

Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1S ,3S)-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)
Journal Article · Fri Jan 23 00:00:00 EST 2015 · Journal of the American Chemical Society · OSTI ID:1171656

Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 S ,3 S )-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)
Journal Article · Tue Feb 10 00:00:00 EST 2015 · Journal of the American Chemical Society · OSTI ID:1171656

Design and Mechanism of Tetrahydrothiophene-Based γ-Aminobutyric Acid Aminotransferase Inactivators
Journal Article · Wed Mar 25 00:00:00 EDT 2015 · Journal of the American Chemical Society · OSTI ID:1171656